Ticker brief
BEAM BEAM THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$29.32
1 day
-3.8%
14 days
+9.6%
mkt cap
$3.6B
signals 14d
20
authors 14d
13
crowd 14d
+1.4σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 89% mid · 72 pctile own 1y | IV/HV 1.47× (as of 2026-08-27) |
| Skew — 25Δ RR 30d | -0.165 7 pctile own 1y | puts bid vs calls (downside bid) |
| Net dealer OI (NDOI) | +0.51 elevated | 5-session Δ -0.34 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-05-28 (z=2.7) |
| Next earnings | 2026-11-03 (proj) | in 67d |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-27 · now +0.55 (−1 bearish … +1 bullish)
Who spoke13
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @hiddensmallcaps | B | -0.77 | 5 | +0.37 |
| @gabz_investing | C | +0.61 | 2 | +0.10 |
| @OptionsFlowBoss | C | · | 2 | +0.38 |
| @Brad_E_Schulz | C | · | 2 | +0.10 |
| @semodough | C | -3.01 | 1 | +0.40 |
| @SteveDJacobs | C | -1.22 | 1 | +0.45 |
| @HyenukChu | C | +0.97 | 1 | +0.10 |
| @OptionsHawk | B | +0.24 | 1 | +0.45 |
| @PeloSwing | C | -0.75 | 1 | +0.60 |
| @Sir_Kory | C | -0.11 | 1 | +0.35 |
| @ArtofSpecuycky | B | +0.68 | 1 | +0.50 |
| @MinervaCap | C | -0.39 | 1 | +0.15 |
| @jimmyhuli | C | -0.15 | 1 | +0.55 |
Recent signals20of 20 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @jimmyhuli | +0.55 | Discloses multiple existing long positions across biotech and AI-related names. | -3.8% | tweet ↗ |
| 2026-08-25 | @MinervaCap | +0.15 | Daily watchlist names top trades for tomorrow without explicit entry intent. | -5.5% | tweet ↗ |
| 2026-08-25 | @ArtofSpecuycky | +0.50 | Presents genomics as a major decade-long investment theme and lists representative stocks. | -5.5% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.10 | Quantifies strong sector breadth and lists leading stocks. | -5.5% | tweet ↗ |
| 2026-08-25 | @Sir_Kory | +0.35 | Frames gene editing as a large long-term market and compares four public platforms by maturity and risk. | -5.5% | tweet ↗ |
| 2026-08-25 | @PeloSwing | +0.60 | Reports heavy buying in far-OTM BEAM calls at $40 for January 2028 and $30 for October. | -5.5% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.10 | Reports quantified intraday performance across stock categories. | -5.5% | tweet ↗ |
| 2026-08-25 | @hiddensmallcaps | +0.00 | References BEAM's pipeline, but the substantive information is only in unseen media. | -5.5% | tweet ↗ |
| 2026-08-25 | @OptionsHawk | +0.45 | BEAM rose 9%, its 30-day implied volatility also gained 9%, and call activity was elevated. | -5.5% | tweet ↗ |
| 2026-08-25 | @hiddensmallcaps | +0.40 | H.C. Wainwright reiterates Buy and maintains an $80 target on Beam. | -5.5% | tweet ↗ |
| 2026-08-25 | @OptionsFlowBoss | +0.55 | Reports bullish positioning in BEAM options. | -5.5% | tweet ↗ |
| 2026-08-23 | @HyenukChu | +0.10 | Presents a genome-sector basket, but the accompanying image is needed for the underlying analysis. | -1.5% | tweet ↗ |
| 2026-08-23 | @SteveDJacobs | +0.45 | Explains a stage-analysis screen where BEAM ranks stronger and IBM shows mean reversion. | -1.5% | tweet ↗ |
| 2026-08-22 | @hiddensmallcaps | +0.45 | Notes a bullish higher-high pattern while BEAM rides its 200-day moving average. | -1.5% | tweet ↗ |
| 2026-08-21 | @gabz_investing | +0.20 | Reports two-day gains after previously issued buy signals. | -1.5% | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.40 | Compares gene-editing basket valuations with IONQ to argue biotech sentiment has room to improve. | -1.5% | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.60 | Expects MRNA news to renew investor interest in PRME, BEAM and related biotechnology names. | -1.5% | tweet ↗ |
| 2026-08-21 | @OptionsFlowBoss | +0.20 | Lists unusually high bullish options-volume multiples; later bearish remark is not assigned to named stocks. | -1.5% | tweet ↗ |
| 2026-08-20 | @gabz_investing | +0.00 | Recaps hypothetical overnight returns from yesterday's signals and proposes a future experiment. | +3.3% | tweet ↗ |
| 2026-08-17 | @semodough | +0.40 | BEAM plans a risto-cel BLA by year-end and a roughly 50-patient A1ATD registration study in 2H26. | +8.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.